GGM Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$266K Sell
631
-1
-0.2% -$542 0.15% 109
2024
Q4
$329K Buy
632
+10
+2% +$5.5K 0.17% 103
2024
Q3
$385K Hold
622
0.17% 93
2024
Q2
$344K Hold
622
0.16% 95
2024
Q1
$366K Hold
622
0.17% 91
2023
Q4
$340K Hold
622
0.14% 104
2023
Q3
$315K Hold
622
0.14% 103
2023
Q2
$323K Buy
+622
New +$336K 0.13% 108
2023
Q1
Sell
-617
Closed -$330K 122
2022
Q4
$330K Hold
617
0.17% 93
2022
Q3
$317K Hold
617
0.17% 99
2022
Q2
$327K Sell
617
-2
-0.3% -$1.1K 0.18% 94
2022
Q1
$355K Buy
+619
New +$356K 0.18% 96

Other funds holding TMO

GGM Wealth Advisors's TMO Position: Q1 2025 in Review

GGM Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.16% in Q1 2025, selling an estimated $542 and leaving 631 shares worth $266K. The position accounts for 0.15% of the portfolio, ranked #109.

GGM Wealth Advisors first reported a position in TMO in Q1 2022 and has held it in 12 quarters since. The position peaked at $385K in Q3 2024. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • GGM Wealth Advisors held 631 shares of Thermo Fisher Scientific worth $266K as of Q1 2025.
  • GGM Wealth Advisors sold 1 Thermo Fisher Scientific share in Q1 2025, an estimated $542.
  • Thermo Fisher Scientific made up 0.15% of GGM Wealth Advisors's portfolio in Q1 2025, its #109 holding.
  • GGM Wealth Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 12 quarters since.
  • GGM Wealth Advisors's Thermo Fisher Scientific position peaked at $385K in Q3 2024.
  • 2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on GGM Wealth Advisors's 13F filing for Q1 2025, filed 1 May 2025.